Skip to main content
OpenTrials

Clinical trial condition

Infections, Rotavirus

Explore clinical trials studying Infections, Rotavirus. Study availability and eligibility vary by location and protocol.

56 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Infections, Rotavirus trial results

Completed

Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks

NCT03954743

Conditions
Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Colorado Springs, Colorado, United States
  • GSK Investigational Site Louisville, Kentucky, United States
  • GSK Investigational Site Frederick, Maryland, United States
View all 37 locations
View Trial Details
Completed

To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination

NCT00353366

Conditions
Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, +7 more
Locations
  • GSK Investigational Site Alabang, Muntinlupa City, Philippines
  • GSK Investigational Site Binangonan, Rizal, Philippines
  • GSK Investigational Site Cainta, Rizal, Philippines
  • GSK Investigational Site City of Muntinlupa, Philippines
View all 18 locations
View Trial Details
Completed

A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa

NCT00263666

Conditions
Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations
  • GSK Investigational Site Attridgerville, Gauteng, South Africa
  • GSK Investigational Site Coronationville, Gauteng, South Africa
  • GSK Investigational Site Garankuwa, North West, South Africa
  • GSK Investigational Site Brits, South Africa
View Trial Details
Completed

Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks

NCT02914184

Conditions
Infections, Infections, Rotavirus, RNA Virus Infections, +4 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Anaheim, California, United States
  • GSK Investigational Site Paramount, California, United States
  • GSK Investigational Site Sacramento, California, United States
View all 66 locations
View Trial Details
Completed

Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants

NCT00969228

Conditions
Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, +7 more
Locations
  • GSK Investigational Site Busan, South Korea
  • GSK Investigational Site Daegu, South Korea
  • GSK Investigational Site Daegu, South Korea
  • GSK Investigational Site Daejeon, South Korea
View all 18 locations
View Trial Details
Completed

A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants.

NCT00140673

Conditions
Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations
  • GSK Investigational Site Villanueva, Mendoza Province, Argentina
  • GSK Investigational Site Belém, Pará, Brazil
  • GSK Investigational Site Concepción, Región Del Biobio, Chile
  • GSK Investigational Site Valparaíso, Valparaiso, Chile
View all 17 locations
View Trial Details

Related conditions